The partnership will give the American pharma giant access to Concerto’s eurekaHealth AI insights platform. More: BMS signs deal with Concerto HealthAI Source: News
read moreThe collaboration is aligned with AstraZeneca’s science-led strategy in oncology. More: AstraZeneca and Daiichi sign .9bn cancer drug deal Source: News
read moreThe cardiovascular outcomes results Amarin rolled out for its fish oil-derived Vascepa may not have impressed everyone, but one leading U.S. health organization is ready to throw its weight behind the drug, even before the FDA weighs in on its
read moreJust a week after promising a €1 billion investment in its headquarters manufacturing site in Germany, Merck KGaA says it will also invest €150 million into its biologics site in Switzerland. More: Merck KGaA injecting €150M into biologics site where
read moreBayer has lost the first U.S. federal trial on claims that its Roundup weedkiller causes cancer. The $80 million award was actually more than the plaintiff had demanded, and it could push the German company to settle the thousands of
read moreAstraZeneca’s Imfinzi is working to grab sales in a rival-free sector of the lung cancer market, and England’s cost watchdogs just gave it a boost. The National Institute for Health and Care Excellence said Thursday it would cover the treatment
read more© 1994 - 2026 B.M. Pharmaceuticals